PAPER Lee S, Lee D, Hong CS, Yang JE, Kang JS, Sung YE, Paik SR
SEARCH RESULTS
16043 RESULTS
PAPER Norwitz NG, Mota AS, Norwitz SG, Clarke K
Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses.
Front Aging Neurosci. 2019;11:184. Epub 2019 Jul 31 PubMed: 31417394PAPER Stanojlovic M, Pallais JP, Kotz CM
Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease.
Front Neurosci. 2019;13:702. Epub 2019 Jul 30 PubMed: 31417337PAPER Tahaei Gilan SS, Yahya Rayat D, Mustafa TA, Aziz FM, Shahpasand K, Akhtari K, Salihi A, Abou-Zied OK, Falahati M
α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency.
Int J Nanomedicine. 2019;14:4637-4648. Epub 2019 Jun 27 PubMed: 31417259PAPER Lemprière S
Connectivity and vulnerability determine α-synuclein spread.
Nat Rev Neurol. 2019 Oct;15(10):559. PubMed: 31417199PAPER Teng Y, Zhao J, Ding L, Ding Y, Zhou P
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
Molecules. 2019 Aug 14;24(16) PubMed: 31416122PAPER Nagashima K, Makioka K, Fujita Y, Ikeda M, Ikeda Y
Clinical usefulness of scales for evaluating cognitive impairment in patients with amyotrophic lateral sclerosis.
J Neurol Sci. 2019 Oct 15;405:116414. Epub 2019 Jul 31 PubMed: 31419623PAPER Spencer PS
Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC.
Front Neurol. 2019;10:754. Epub 2019 Jul 31 PubMed: 31417480PAPER Lanthier C, Payan H, Liparulo I, Hatat B, Lecoutey C, Since M, Davis A, Bergamini C, Claeysen S, Dallemagne P, Bolognesi ML, Rochais C
Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease.
Eur J Med Chem. 2019 Nov 15;182:111596. Epub 2019 Aug 6 PubMed: 31419776PAPER Amir Rawa MS, Hassan Z, Murugaiyah V, Nogawa T, Wahab HA
Anti-cholinesterase potential of diverse botanical families from Malaysia: Evaluation of crude extracts and fractions from liquid-liquid extraction and acid-base fractionation.
J Ethnopharmacol. 2019 Dec 5;245:112160. Epub 2019 Aug 13 PubMed: 31419500PAPER Gross TJ, Doran E, Cheema AK, Head E, Lott IT, Mapstone M
Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease.
Dev Neurobiol. 2019 Jul;79(7):622-638. Epub 2019 Aug 26 PubMed: 31419370PAPER Wei EX, Oh ES, Harun A, Ehrenburg M, Xue QL, Simonsick E, Agrawal Y
Increased Prevalence of Vestibular Loss in Mild Cognitive Impairment and Alzheimer's Disease.
Curr Alzheimer Res. 2019;16(12):1143-1150. PubMed: 31418661PAPER Sturzu A, Sheikh S, Kalbacher H, Nägele T, Weidenmaier C, Wegenast-Braun BM, Schilling N, Ernemann U, Heckl S
Synthesis of a Novel Curcumin Derivative as a Potential Imaging Probe in Alzheimer's Disease Imaging.
Curr Alzheimer Res. 2019;16(8):723-731. PubMed: 31418660PAPER Krishna KV, Wadhwa G, Alexander A, Kanojia N, Saha RN, Kukreti R, Singhvi G, Dubey SK
Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery.
ACS Chem Neurosci. 2019 Sep 18;10(9):4124-4135. Epub 2019 Aug 29 PubMed: 31418556PAPER Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials.
Alzheimers Dement (N Y). 2019;5:354-363. Epub 2019 Aug 2 PubMed: 31417957Current Filters
- Date Range : Aug 2018 to Aug 2019 x